Today I further increased my position in Kimberly-Clark ($KMB (-1,93 %) ) further increased. 📈
After the share price drop following the announcement of the acquisition of Kenvue ($KVUE (-1,88 %) ) (Tylenol, Neutrogena, Listerine), I saw an exciting opportunity to strengthen my position in a solid dividend stock. 💊🧴
I see Kimberly-Clark as a defensive value stock with a strong brand portfolio and a long-term focus on stability. 🔒
✅ Over 50 years of dividend growth 💰
✅ Current yield of around ~5% 📊
✅ Globally renowned consumer and healthcare brands
Of course, the takeover also entails risks - integration costs, debt and potential legal issues surrounding Tylenol ⚖️ - but in the long term this could result in synergies and growth potential. 🌱
I am clearly focusing on long-term dividend power here and consider the share to be a defensive pillar in the portfolio - not a quick trade, but an investment in brands that should still be in every household in 10 years' time. 🏠💪
How do you see the takeover - opportunity or risk for Kimberly-Clark? 🤔 Possibly on the way to becoming a "Procter& Gamble ($PG (+0,16 %) ) 2.0" 💥🔮 (Not entirely serious, of course...😋)
#Dividenden
#aktien
#buyandhold
#buythedip
#Langfristig
#nachkauf
